Company · CIK 0001217234 · SIC 8071 — Services-Medical Laboratories · Nasdaq
CareDx, Inc. · CDNA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2026 FForm 4 → | Sep 15, 5:11 pm EDT | Keith KennedyCFO & COO | 8,220 | $52.37 | $430,481 | 211,704 | — | |
| Sep 12, 2026 FForm 4 → | Sep 15, 5:11 pm EDT | Jessica MengChief Commercial Officer | 6,688 | $52.37 | $350,251 | 161,599 | — | |
| Aug 5, 2026 SForm 4 → | Aug 6, 4:10 pm EDT | George BickerstaffDirector | 20,000 | $46.29 | $925,700 | 134,061 | −13.0% | |
| Aug 5, 2026 SForm 4 → | Aug 6, 4:05 pm EDT | Jeffrey Adam NovackSecretary and General Counsel | 2,688 | $46.26 | $124,349 | 106,075 | −2.47% | 10b5-1 |
| Aug 4, 2026 SForm 4 → | Aug 6, 4:10 pm EDT | Christine CournoyerDirector | 16,000 | $46.94 | $750,973 | 42,943 | −27.1% | 10b5-1 |
| Aug 4, 2026 SForm 4 → | Aug 6, 4:05 pm EDT | Michael GoldbergDirector | 44,700 | $47.06 | $2,103,497 | 61,738 | −42.0% | |
| Aug 1, 2026 FForm 4 → | Aug 4, 7:41 pm EDT | Jeffrey Adam NovackSecretary and General Counsel | 2,872 | $47.85 | $137,425 | 108,763 | — | |
| Jul 16, 2026 SForm 4 → | Jul 17, 4:23 pm EDT | John Walter Hanna Jr.President and CEO, Director | 118,000 | $37.79 | $4,458,637 | 653,448 | −15.3% | 10b5-1 |
| Jul 16, 2026 MForm 4 → | Jul 17, 4:23 pm EDT | John Walter Hanna Jr.President and CEO, Director | 118,000 | $8.20 | $967,600 | 771,448 | — | 10b5-1 |
| Jul 16, 2026 SForm 4 → | Jul 17, 4:22 pm EDT | Hannah ValantineDirector | 28,779 | $36.15 | $1,040,243 | 36,686 | −44.0% | 10b5-1 |
| Jul 16, 2026 MForm 4 → | Jul 17, 4:22 pm EDT | Hannah ValantineDirector | 28,779 | $14.76 | $424,895 | 65,465 | — | 10b5-1 |
| Jul 2, 2026 AForm 4 → | Jul 7, 5:53 pm EDT | Michael GoldbergDirector | 1,746 | — | — | 106,438 | — | |
| Jul 1, 2026 FForm 4 → | Jul 6, 4:05 pm EDT | John Walter Hanna Jr.President and CEO, Director | 8,511 | $29.25 | $248,947 | 653,448 | — | |
| Jul 1, 2026 FForm 4 → | Jul 2, 4:02 pm EDT | Jeffrey Adam NovackSecretary and General Counsel | 997 | $29.25 | $29,162 | 111,635 | — | |
| Jul 1, 2026 FForm 4 → | Jul 2, 4:01 pm EDT | Jessica MengChief Commercial Officer | 2,411 | $29.25 | $70,522 | 168,287 | — | |
| Jul 1, 2026 FForm 4 → | Jul 2, 4:00 pm EDT | Keith KennedyCFO & COO | 2,930 | $29.25 | $85,703 | 219,924 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 MForm 4 → | Jul 17, 4:23 pm EDT | John Walter Hanna Jr.President and CEO, Director | 118,000 | — | — | 512,706 | — | 10b5-1 |
| Jul 16, 2026 MForm 4 → | Jul 17, 4:22 pm EDT | Hannah ValantineDirector | 28,779 | — | — | 24,011 | — | 10b5-1 |